Darifenacin Impurity 19 | CAS 1207114-13-3 - Request Quote
Darifenacin Impurity 19
| SZ CAT No: | SZ-D004078 |
| CAS No | 1207114-13-3 |
| Mol.F. | C10H11BrO |
| Mol.Wt. |
227.1 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Darifenacin Impurity 19 is chemically 6-(2-Bromoethyl)-2,3-dihydrobenzofuran. Darifenacin Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Darifenacin Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Darifenacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1207114-13-3
Purchase 1207114-13-3
Order 1207114-13-3
Enquire 1207114-13-3
price of 1207114-13-3
1207114-13-3 Supplier
1207114-13-3 Manufacturer
1207114-13-3 Exporter
buy high quality Darifenacin Impurity 19
Purchase Darifenacin Impurity 19
Darifenacin Impurity 19 suppliers
Darifenacin Impurity 19 manufacturers
Darifenacin Impurity 19 price
Order Darifenacin Impurity 19
Enquire Darifenacin Impurity 19
Darifenacin Impurity 19 cost
Darifenacin Impurity 19 Supplier
Darifenacin Impurity 19 Distributor
Darifenacin Impurity 19 for Method Validation
Darifenacin Reference Standard
Darifenacin Impurity 19 for ANDA Filing
Darifenacin Impurity 19 for Forced Degradation Studies
Darifenacin Impurity 19 Identification Standards
Darifenacin Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.